March 2026
1. BETANCOURT M, Kaur R, Gamez J, Price J, et al
   Temporal Trends in Hepatitis C Virus (HCV) Screening and Management in Pregnant Women and Infants between 2014 - 2024 in San Francisco, California.
   Am J Gastroenterol. 2026 Mar 31. doi: 10.14309/ajg.0000000000004014.
   

   >> Share

   
   April 2025
2. MOON AM, Lupu GV, Green EW, Deutsch-Link S, et al
   Rural-urban disparities in hepatocellular carcinoma deaths are driven by hepatitis C-related HCC.
   Am J Gastroenterol. 2025 Apr 11. doi: 10.14309/ajg.0000000000003487.
   

   >> Share

   
   February 2024
3. BUI H, Kumar NG, Singal AG, Boparai J, et al
   Implementation of a hepatocellular carcinoma surveillance program in a community-based integrated health system in patients with hepatitis C cirrhosis.
   Am J Gastroenterol. 2024 Feb 9. doi: 10.14309/ajg.0000000000002704.
   

   >> Share

   
   December 2023
4. HU TH, Luh DL, Tsao YY, Lin TY, et al
   Utilizing the Diabetes Care System for A County-wide Hepatitis C Elimination: An Integrated Community-based Shared Care Model in Taiwan.
   Am J Gastroenterol. 2023 Dec 12. doi: 10.14309/ajg.0000000000002624.
   

   >> Share

   
   
5. BARRITT AS 4TH, Barnhart H, Gu J, Dellinger A, et al
   When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
   Am J Gastroenterol. 2023;118:2301-2304.
   

   >> Share

   
   July 2023
6. BARNHILL MS, Vargas HE
   Immune-Checkpoint Inhibitors in the Hepatitis C-Infected Patient: To Use or Not to Use?
   Am J Gastroenterol. 2023 Jul 10. doi: 10.14309/ajg.0000000000002352.
   

   >> Share

   
   June 2023
7. YIBIRIN M, Mustafayev K, Hosry J, Pundhir P, et al
   Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients with Solid Tumors.
   Am J Gastroenterol. 2023 Jun 13. doi: 10.14309/ajg.0000000000002361.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share